MX2018011680A - Composiciones que comprenden colina y su uso. - Google Patents
Composiciones que comprenden colina y su uso.Info
- Publication number
- MX2018011680A MX2018011680A MX2018011680A MX2018011680A MX2018011680A MX 2018011680 A MX2018011680 A MX 2018011680A MX 2018011680 A MX2018011680 A MX 2018011680A MX 2018011680 A MX2018011680 A MX 2018011680A MX 2018011680 A MX2018011680 A MX 2018011680A
- Authority
- MX
- Mexico
- Prior art keywords
- choline
- potential
- composition
- compositions
- female subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
La presente invención se refiere a una composición que comprende colina para usar en la promoción, apoyo u optimización de uno o más de los siguientes: (i) mielinización de novo; (ii) estructura del cerebro; (iii) conectividad del cerebro; (iv) potencial intelectual; (v) potencial cognitivo; (vi) potencial de aprendizaje; y (vi) función cognitiva. en una cría de un sujeto femenino, en donde dicha composición es para la administración al sujeto femenino.
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662315158P | 2016-03-30 | 2016-03-30 | |
| US201662315163P | 2016-03-30 | 2016-03-30 | |
| US201662315142P | 2016-03-30 | 2016-03-30 | |
| US201662315152P | 2016-03-30 | 2016-03-30 | |
| US201662315134P | 2016-03-30 | 2016-03-30 | |
| US201662328105P | 2016-04-27 | 2016-04-27 | |
| PCT/EP2016/080790 WO2017167417A1 (en) | 2016-03-30 | 2016-12-13 | Compositions comprising choline and their use |
| PCT/EP2017/057571 WO2017167895A1 (en) | 2016-03-30 | 2017-03-30 | Compositions comprising choline and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018011680A true MX2018011680A (es) | 2019-01-10 |
Family
ID=57758563
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018008518A MX2018008518A (es) | 2016-03-30 | 2016-12-13 | Composiciones que comprenden colina y su uso. |
| MX2018011680A MX2018011680A (es) | 2016-03-30 | 2017-03-30 | Composiciones que comprenden colina y su uso. |
| MX2022012236A MX2022012236A (es) | 2016-03-30 | 2018-09-25 | Composiciones que comprenden colina y su uso. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018008518A MX2018008518A (es) | 2016-03-30 | 2016-12-13 | Composiciones que comprenden colina y su uso. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022012236A MX2022012236A (es) | 2016-03-30 | 2018-09-25 | Composiciones que comprenden colina y su uso. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3435991A1 (es) |
| CN (2) | CN108697671A (es) |
| BR (2) | BR112018011394A2 (es) |
| CA (2) | CA3003656A1 (es) |
| MX (3) | MX2018008518A (es) |
| PH (1) | PH12018501782A1 (es) |
| SG (2) | SG11201803026RA (es) |
| WO (2) | WO2017167417A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201900604TA (en) * | 2019-01-23 | 2020-08-28 | Agency For Science Technology And Research Astarstar | Pre-natal beta-cryptoxanthin benefits children |
| WO2021231566A1 (en) * | 2020-05-12 | 2021-11-18 | Massachusetts Institute Of Technology | The use of choline supplementation as therapy for apoe4-related disorders |
| CN112655969A (zh) * | 2021-03-15 | 2021-04-16 | 江苏艾兰得营养品有限公司 | 酒石酸氢胆碱颗粒、含有其的片剂及制备方法 |
| WO2024038010A1 (en) | 2022-08-18 | 2024-02-22 | Société des Produits Nestlé S.A. | Kit to promote developmental myelination |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE84680T1 (de) | 1987-12-23 | 1993-02-15 | Nestle Sa | Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels. |
| EP0880902A1 (fr) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Procédé de traitement d'une matiére première lactosérique |
| WO1999063943A2 (en) * | 1998-06-12 | 1999-12-16 | Craig Anthony Cooney | Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring |
| US6777391B1 (en) | 1999-04-29 | 2004-08-17 | Nestec S.A. | Composition for an infant formula having a low threonine content |
| CN1778199A (zh) * | 2004-11-24 | 2006-05-31 | 王维义 | 孕产妇营养素 |
| CN101316521B (zh) * | 2005-04-28 | 2014-06-25 | 恩兹默泰克有限公司 | 极性脂质混合物、其制备和应用 |
| EP2110027A1 (en) * | 2008-04-01 | 2009-10-21 | Nestec S.A. | Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation |
| EP2258217A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Children |
| EP2258218A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
| ITGE20110050A1 (it) * | 2011-04-29 | 2012-10-30 | Marco Zipoli | Alimento, in particolare una bevanda per l'alimentazione umana |
| CN108366601A (zh) * | 2015-12-14 | 2018-08-03 | 雀巢产品技术援助有限公司 | 促进大脑髓鞘形成的营养组合物和婴儿配方食品 |
| EP4233875A3 (en) * | 2015-12-14 | 2023-09-06 | Société des Produits Nestlé S.A. | Nutritional composition an infant formula for prmoting de novo myelination |
| EP4233907A3 (en) * | 2015-12-14 | 2024-01-10 | Société des Produits Nestlé S.A. | Nutritional compositions and infant formulas to promote myelination in the brain |
-
2016
- 2016-12-13 CA CA3003656A patent/CA3003656A1/en not_active Abandoned
- 2016-12-13 BR BR112018011394A patent/BR112018011394A2/pt not_active IP Right Cessation
- 2016-12-13 CN CN201680072990.7A patent/CN108697671A/zh active Pending
- 2016-12-13 WO PCT/EP2016/080790 patent/WO2017167417A1/en active Application Filing
- 2016-12-13 MX MX2018008518A patent/MX2018008518A/es unknown
- 2016-12-13 SG SG11201803026RA patent/SG11201803026RA/en unknown
-
2017
- 2017-03-30 BR BR112018067423A patent/BR112018067423A2/pt not_active Application Discontinuation
- 2017-03-30 CA CA3017842A patent/CA3017842A1/en active Pending
- 2017-03-30 MX MX2018011680A patent/MX2018011680A/es unknown
- 2017-03-30 EP EP17714729.5A patent/EP3435991A1/en active Pending
- 2017-03-30 SG SG11201806422XA patent/SG11201806422XA/en unknown
- 2017-03-30 WO PCT/EP2017/057571 patent/WO2017167895A1/en active Application Filing
- 2017-03-30 CN CN201780012452.3A patent/CN108697672A/zh active Pending
-
2018
- 2018-08-22 PH PH12018501782A patent/PH12018501782A1/en unknown
- 2018-09-25 MX MX2022012236A patent/MX2022012236A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN108697671A (zh) | 2018-10-23 |
| PH12018501782A1 (en) | 2019-06-17 |
| CA3003656A1 (en) | 2017-10-05 |
| WO2017167895A1 (en) | 2017-10-05 |
| CA3017842A1 (en) | 2017-10-05 |
| MX2022012236A (es) | 2023-01-24 |
| EP3435991A1 (en) | 2019-02-06 |
| BR112018011394A2 (pt) | 2018-12-04 |
| SG11201803026RA (en) | 2018-05-30 |
| BR112018067423A2 (pt) | 2019-01-22 |
| WO2017167417A1 (en) | 2017-10-05 |
| CN108697672A (zh) | 2018-10-23 |
| MX2018008518A (es) | 2018-08-16 |
| SG11201806422XA (en) | 2018-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3984532A3 (en) | Compositions comprising choline and their use | |
| MX2022012236A (es) | Composiciones que comprenden colina y su uso. | |
| AU2018236800B2 (en) | DNA-PK inhibitors | |
| PH12017501956A1 (en) | Compositions of obeticholic acid and methods of use | |
| MX2022012374A (es) | Composiciones multi-suplementos. | |
| PH12018500833A1 (en) | Compositions and their use | |
| MX2017013562A (es) | Reguladores de microbioma y usos relacionados de los mismos. | |
| SG10201909545XA (en) | Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof | |
| EP4292600A3 (en) | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells | |
| NZ631601A (en) | Solid forms of a thiophosphoramidate nucleotide prodrug | |
| MX2022012237A (es) | Composiciones que comprenden fosfolipido y su uso. | |
| PH12017501692A1 (en) | Solid forms of menaquinols | |
| MX2019011613A (es) | Formulaciones de acido 1-amino-1-ciclopropanocarboxilico. | |
| BR112017024855A2 (pt) | métodos de produção de aldc | |
| MX2022014682A (es) | Composiciones y su uso. | |
| WO2017167898A3 (en) | Compositions comprising vitamins and their use | |
| MX2021006993A (es) | Analogos de nucleosidos de ciclopentilo como antivirales. | |
| PH12018501029A1 (en) | Compositions comprising choline and their use | |
| MX2018006293A (es) | Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro. | |
| MX353587B (es) | Formulaciones farmacéuticas que contienen ipidacrina y su uso para el tratamiento de trastornos de potencia y trastornos de otras formas de actividad sexual. |